Cellular targets for angiotensin II fragments: pharmacological and molecular evidence. - sprookjes - yvandenbroek - TriplyDB

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.

http://www.wikidata.org/entity/Q35065512

about

A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases Effects of age, genes, and pulse pressure on executive functions in healthy adults Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression.Binding to and Inhibition of Insulin-Regulated Aminopeptidase by Macrocyclic Disulfides Enhances Spine Density.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7)Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.Angiotensin converting enzyme 2 in the kidney.Exogenous Angiotensin I Metabolism in Aorta Isolated from Streptozotocin Treated Diabetic Rats.The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease.The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.A comparison of the effects of Angiotensin IV on androgen-dependent and androgen-independent prostate cancer cell lines.Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension.Local expression of AP/AngIV/IRAP and effect of AngIV on glucose-induced epithelial transport in human jejunal mucosa.Physiological and pathophysiological functions of different angiotensins in the brain.Age differences in arterial and venous extra-cerebral blood flow in healthy adults: contributions of vascular risk factors and genetic variants.Conformational constraints in angiotensin IV to probe the role of Tyr², Pro⁵ and Phe⁶.Angiotensin IV and the human esophageal mucosa: An exploratory study in healthy subjects and gastroesophageal reflux disease patients.

P2860

Q26861984-24E14ED4-A5C6-41B3-9774-4D3E837B2D20 Q33939121-06EA2AD6-C5F1-4606-A665-B248AB39350A Q34543485-940FFE24-9C8D-4FD1-BBF7-3F339C1E3B3B Q34784864-1A8462AC-87B6-4420-B1BD-07E9D34419EE Q35680552-DFCAAD4F-B892-4B84-9BD1-3427F0738E3D Q35894732-591FF0BC-34A1-40E7-9370-3E982AC017C9 Q36241932-0478AAA9-69F7-4A00-93E4-4583E6634A7B Q36480563-89145B48-9FCC-4919-BCAC-B400EE858FFD Q36576477-FEECFA7C-E83F-4771-8D48-F6B3CD9D9238 Q37045324-A51F2104-7F18-47A4-B2B3-B9A0BA3BFD4A Q37097117-CFC3BEFD-3DF3-47FC-880E-A432304C0C25 Q37359774-C412C0A7-C9E8-41E7-8E30-1032580D9D48 Q37363586-356FE49A-79F8-4D75-A7B2-A128180622A5 Q38005611-411B98ED-8BB3-4C1F-A555-4A34E9D04967 Q38217456-AA8D1770-E608-460D-A351-D7885F5520E8 Q39334872-5AE9EC4C-6117-45CB-947A-56F6A47D2929 Q39586636-1EC15244-CB03-4D97-B8CD-7426DC10E96D Q40603698-8E3DEEFA-46D4-40F2-9C51-E200A8902E78 Q46322831-A5B18FA2-81F0-4B9A-91B5-0DB000790129 Q48340994-1FED895E-BD7C-44C3-B0AD-2C18E8CEF22A Q51768228-95160DAE-9D71-4236-B921-EF98D69E6DE3 Q54226745-4149105F-5AEC-4E35-BB9A-BC6A7FE2A810

P2860

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.

http://www.wikidata.org/entity/Q35065512

description

2002 nî lūn-bûn

@nan

2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.

@ast

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.

@en

type

label

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.

@ast

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.

@en

prefLabel

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.

@ast

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.

@en

P1433

Q35065512-78F84DCB-BFAE-4F7D-85A5-7A331E14199B

P1476

Q35065512-81A48FFE-6D18-4DC3-9840-319436D92D9C

P2093

Q35065512-14435739-6A21-47E7-B398-5C707B47E8AC

Q35065512-2903B38C-2089-43CE-8F3B-022BAB5EFF62

Q35065512-33EE0EBC-6FF7-464E-A74C-E9599D767169

Q35065512-403D5BD4-DFBB-4A9A-B323-2F81AD9F3B7E

Q35065512-71C12070-63F8-498F-94C8-9890B9C336F8

Q35065512-9BB57B5C-DF2A-4096-9418-87CB07A335FC

P2860

Q35065512-01F0AFAF-27C7-43CA-977E-0E51C3BBC7AA

Q35065512-04282A09-C084-4680-AB3D-06D87007F575

Q35065512-0825BCC6-1623-43FA-8314-8F88965297C5

Q35065512-08AC021B-EF23-422B-B3A5-1D118583DCA6

Q35065512-09D9E3BB-ABD0-4F92-85D7-C20862EDF166

Q35065512-0BEB9F53-1D37-4571-8EB9-BB6D387CE512

Q35065512-0DB13CD2-D920-436A-A563-0C830CD811BB

Q35065512-0E15229E-6820-496A-8052-24625780212A

Q35065512-0EC9502C-FCAA-4AD3-B1FB-65C945B601B2

Q35065512-1645CF39-3CAB-4183-9BA6-89D5680D9FD7

P304

Q35065512-9A33E340-02A8-4A4C-9A20-965E6E2C11A6

P31

Q35065512-DA2CEB99-7B50-4F61-B521-893173B5B320

P356

Q35065512-B9AEC233-0133-409A-ADA1-9B110D724BBB

P433

Q35065512-B7F05B11-8BA3-4785-B742-762483B25816

P478

Q35065512-B604A883-D18B-4C2A-ACD9-E265EC35433E

P50

Q35065512-A49D7C14-BB77-4829-928B-8C9F859E3F22

P577

Q35065512-91095EFE-5391-413F-9510-AEF98E0FA0E4

P5875

Q35065512-89AC081F-80B0-4E3D-ACFB-CAA803E956E7

P698

Q35065512-4A644127-16FA-4EBA-9474-E1F4727546AB

P356

P1433

Journal of the Renin-Angiotensin-Aldosterone System

P1476

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence

@en

P2093

Alain Dupont

http://www.w3.org/2001/XMLSchema#string

Georges Vauquelin

http://www.w3.org/2001/XMLSchema#string

Guy Ebinger

http://www.w3.org/2001/XMLSchema#string

Patrick Vanderheyden

http://www.w3.org/2001/XMLSchema#string

Sophie Sarre

http://www.w3.org/2001/XMLSchema#string

Yvette Michotte

http://www.w3.org/2001/XMLSchema#string

P2860

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

Human placental leucine aminopeptidase/oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family

Structural organization of the 5'-end and chromosomal assignment of human placental leucine aminopeptidase/insulin-regulated membrane aminopeptidase gene

Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides

Angiotensin receptors in the nervous system

Identification of human placental leucine aminopeptidase as oxytocinase

Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system

Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release

Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice

Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles

P304

195-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3317/JRAAS.2002.041

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10901598

http://www.w3.org/2001/XMLSchema#string

P698

12584663

http://www.w3.org/2001/XMLSchema#string